Length of stay in pediatric intensive care unit: prediction model

Simone Brandi1, Eduardo Juan Troster2, Mariana Lucas da Rocha Cunha2

  • 1Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Insights

A predictive model for pediatric intensive care unit length of stay risk showed modest accuracy. The model

Area of Science:

  • Pediatric Intensive Care
  • Medical Informatics
  • Clinical Prediction Models

Background:

  • Accurate prediction of pediatric intensive care unit (PICU) length of stay (LOS) is crucial for resource allocation and patient management.
  • Existing models often lack precision, necessitating development of improved predictive tools.

Purpose of the Study:

  • To develop and validate a predictive model for estimating the risk of prolonged length of stay in children admitted to a PICU.
  • The model utilizes demographic and clinical data available at the time of admission.

Main Methods:

  • Retrospective cohort study conducted in Sao Paulo, Brazil.
  • Internal validation procedures were employed.
  • Area under the Receiver Operating Characteristic (ROC) curve was used to assess model performance.

Main Results:

  • The mean hospital stay was 2 days.
  • The predictive model segmented hospital stay into 1-2, 3-4, and >4 day categories.
  • Model accuracy for 3-4 days was 0.71 (65% correct), and for >4 days was 0.69 (66% correct), indicating modest predictive capability.

Conclusions:

  • The developed predictive model demonstrated limited accuracy, making it insufficient for sole reliance in decision-making or discharge planning.
  • Predictive models for PICU LOS based solely on admission data are constrained by their inability to incorporate in-hospital events like complications, impacting overall accuracy.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
127
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
159
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
545